23.82
Precedente Chiudi:
$24.11
Aprire:
$24.16
Volume 24 ore:
42,192
Relative Volume:
0.12
Capitalizzazione di mercato:
$165.25M
Reddito:
-
Utile/perdita netta:
$-112.46M
Rapporto P/E:
-14.53
EPS:
-1.64
Flusso di cassa netto:
$-99.89M
1 W Prestazione:
-15.54%
1M Prestazione:
-36.57%
6M Prestazione:
+79.62%
1 anno Prestazione:
+47.61%
Vor Biopharma Inc Stock (VOR) Company Profile
Nome
Vor Biopharma Inc
Settore
Industria
Telefono
617-655-6580
Indirizzo
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Confronta VOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
VOR
Vor Biopharma Inc
|
23.82 | 165.25M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.18 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.68 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
827.86 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-06-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Iniziato | Wedbush | Outperform |
| 2022-04-27 | Iniziato | Goldman | Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-02 | Iniziato | Oppenheimer | Outperform |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-03-03 | Iniziato | Evercore ISI | Outperform |
| 2021-03-02 | Iniziato | Goldman | Sell |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Vor Biopharma Appoints New Chief Medical Officer - TipRanks
Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer - GlobeNewswire
Forecasting Vor Biopharma Inc. price range with options dataMarket Trend Review & Risk Managed Investment Strategies - newser.com
Technical signs of recovery in Vor Biopharma Inc.July 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Vor Biopharma Inc. stock retracement – recovery analysis2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Risk adjusted return profile for Vor Biopharma Inc. analyzedJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Vor Biopharma Inc. stock volume spike explainedVolume Spike & Community Trade Idea Sharing - newser.com
Will Vor Biopharma Inc. stock gain from government policiesQuarterly Profit Report & Real-Time Stock Movement Alerts - newser.com
Long term hold vs stop loss in Vor Biopharma Inc.Weekly Trend Recap & Fast Entry Momentum Alerts - newser.com
Applying big data sentiment scoring on Vor Biopharma Inc.Day Trade & Weekly Market Pulse Updates - newser.com
Vor Biopharma Inc. stock chart pattern explainedJuly 2025 Technicals & Verified Swing Trading Watchlists - newser.com
How currency fluctuations impact Vor Biopharma Inc. stockWeekly Investment Recap & Smart Money Movement Tracker - newser.com
Using data models to predict Vor Biopharma Inc. stock movementWeekly Risk Report & Weekly Stock Performance Updates - newser.com
Pattern recognition hints at Vor Biopharma Inc. upsideQuarterly Portfolio Report & Long-Term Safe Return Strategies - newser.com
Published on: 2025-11-02 01:05:22 - newser.com
Q3 EPS Estimates for Vor Biopharma Boosted by HC Wainwright - MarketBeat
Combining price and volume data for Vor Biopharma Inc.Weekly Loss Report & Weekly Watchlist of Top Performers - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsCPI Data & Daily Profit Maximizing Tips - newser.com
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 124,311 Shares - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 251,518 Shares - MarketBeat
RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Vor Biopharma Inc. - GuruFocus
Vor Bio (NASDAQ: VOR) issues inducement equity to 20 new hires at $30.22 per share - Stock Titan
FY2028 EPS Estimates for Vor Biopharma Decreased by Analyst - MarketBeat
Published on: 2025-10-31 05:21:03 - newser.com
Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million By Investing.com - Investing.com Nigeria
Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million - Investing.com
VOR Form 4: RA Capital reports multi-day insider stock sales - Stock Titan
Vor Biopharma Inc. (VOR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Vor Biopharma (NASDAQ:VOR) Price Target Raised to $52.00 - MarketBeat
Can Vor Biopharma Inc. stock maintain operating marginsWeekly Investment Report & Verified Entry Point Signals - newser.com
Vor Biopharma (VOR) Price Target Increased by 30.77% to 47.68 - Nasdaq
Vor Biopharma (VOR) Stock Target Price Raised by HC Wainwright & - GuruFocus
Vor Biopharma Says Telitacicept Sustains Efficacy in Phase 3 Myasthenia Gravis Trial in China - MarketScreener
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Vor Biopharma Inc Azioni (VOR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 28 '25 |
Sale |
27.42 |
124,311 |
3,408,230 |
1,055,749 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 30 '25 |
Sale |
25.12 |
24,579 |
617,424 |
779,652 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 27 '25 |
Sale |
28.12 |
90,941 |
2,557,261 |
1,180,060 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 23 '25 |
Sale |
28.01 |
76,880 |
2,153,409 |
1,324,346 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 24 '25 |
Sale |
28.01 |
53,345 |
1,494,193 |
1,271,001 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 20 '25 |
Sale |
29.67 |
92,023 |
2,730,483 |
0 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 21 '25 |
Sale |
28.11 |
25,027 |
703,509 |
1,401,226 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 17 '25 |
Sale |
30.25 |
25,717 |
777,987 |
1,178,725 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 20 '25 |
Sale |
30.05 |
11,616 |
349,101 |
1,167,109 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 21 '25 |
Sale |
30.07 |
200 |
6,015 |
1,166,909 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):